IRIS Accounts Production v24.3.2.46 11601433 director 1.11.23 31.10.24 31.10.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh116014332023-10-31116014332024-10-31116014332023-11-012024-10-31116014332022-10-31116014332022-11-012023-10-31116014332023-10-3111601433ns15:EnglandWales2023-11-012024-10-3111601433ns14:PoundSterling2023-11-012024-10-3111601433ns10:Director12023-11-012024-10-3111601433ns10:PrivateLimitedCompanyLtd2023-11-012024-10-3111601433ns10:SmallEntities2023-11-012024-10-3111601433ns10:AuditExempt-NoAccountantsReport2023-11-012024-10-3111601433ns10:SmallCompaniesRegimeForDirectorsReport2023-11-012024-10-3111601433ns10:SmallCompaniesRegimeForAccounts2023-11-012024-10-3111601433ns10:FullAccounts2023-11-012024-10-3111601433ns5:CurrentFinancialInstruments2024-10-3111601433ns5:CurrentFinancialInstruments2023-10-3111601433ns5:Non-currentFinancialInstruments2024-10-3111601433ns5:Non-currentFinancialInstruments2023-10-3111601433ns5:ShareCapital2024-10-3111601433ns5:ShareCapital2023-10-3111601433ns5:RetainedEarningsAccumulatedLosses2024-10-3111601433ns5:RetainedEarningsAccumulatedLosses2023-10-3111601433ns10:RegisteredOffice2023-11-012024-10-3111601433ns5:FurnitureFittings2023-11-012024-10-3111601433ns5:ComputerEquipment2023-11-012024-10-3111601433ns5:FurnitureFittings2023-10-3111601433ns5:ComputerEquipment2023-10-3111601433ns5:FurnitureFittings2024-10-3111601433ns5:ComputerEquipment2024-10-3111601433ns5:FurnitureFittings2023-10-3111601433ns5:ComputerEquipment2023-10-3111601433ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-3111601433ns5:WithinOneYearns5:CurrentFinancialInstruments2023-10-31116014331ns10:Director12023-10-31116014331ns10:Director12022-10-31116014331ns10:Director12023-11-012024-10-31116014331ns10:Director12022-11-012023-10-31116014331ns10:Director12024-10-31116014331ns10:Director12023-10-3111601433ns10:Director22023-11-012024-10-3111601433ns10:Director222023-10-3111601433ns10:Director222022-10-3111601433ns10:Director222023-11-012024-10-3111601433ns10:Director222022-11-012023-10-3111601433ns10:Director222024-10-3111601433ns10:Director222023-10-31
REGISTERED NUMBER: 11601433 (England and Wales)














Unaudited Financial Statements

for the Year Ended 31 October 2024

for

Mediprotect Healthcare Limited

Mediprotect Healthcare Limited (Registered number: 11601433)






Contents of the Financial Statements
for the Year Ended 31 October 2024




Page

Balance Sheet 1

Notes to the Financial Statements 2


Mediprotect Healthcare Limited (Registered number: 11601433)

Balance Sheet
31 October 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 535 713

CURRENT ASSETS
Debtors 5 70,000 76,784
Cash at bank 41,445 28,208
111,445 104,992
CREDITORS
Amounts falling due within one year 6 63,561 56,923
NET CURRENT ASSETS 47,884 48,069
TOTAL ASSETS LESS CURRENT LIABILITIES 48,419 48,782

CREDITORS
Amounts falling due after more than one year 7 (16,056 ) (18,503 )

PROVISIONS FOR LIABILITIES (134 ) (175 )
NET ASSETS 32,229 30,104

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 32,129 30,004
SHAREHOLDERS' FUNDS 32,229 30,104

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director and authorised for issue on 10 January 2025 and were signed by:





J J Legge - Director


Mediprotect Healthcare Limited (Registered number: 11601433)

Notes to the Financial Statements
for the Year Ended 31 October 2024

1. STATUTORY INFORMATION

Mediprotect Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 11601433

Registered office: Ebenezer House
Ryecroft
Newcastle-Under-Lyme
Staffordshire
ST5 2BE

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue is recognised as the company becomes entitled to consideration for the goods and services supplied. Therefore, turnover also includes the element of work completed but not yet invoiced on service contracts.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Mediprotect Healthcare Limited (Registered number: 11601433)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 November 2023
and 31 October 2024 1,496 2,050 3,546
DEPRECIATION
At 1 November 2023 783 2,050 2,833
Charge for year 178 - 178
At 31 October 2024 961 2,050 3,011
NET BOOK VALUE
At 31 October 2024 535 - 535
At 31 October 2023 713 - 713

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 70,000 76,784

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts - 6,443
Taxation and social security 54,282 41,569
Other creditors 9,279 8,911
63,561 56,923

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Other creditors 16,056 18,503

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 October 2024 and 31 October 2023:

2024 2023
£    £   
J J Legge
Balance outstanding at start of year 18,930 26,376
Amounts advanced 7,641 -
Amounts repaid (26,649 ) (7,446 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (78 ) 18,930

Mediprotect Healthcare Limited (Registered number: 11601433)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2024

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES - continued

J M Brittain
Balance outstanding at start of year 16,867 25,942
Amounts repaid (16,867 ) (9,075 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - 16,867